MedTrace Logo

Evaluation of Cissus Verticillata L. Infusion in Controlling Type 2 Diabetes

NCT01145534 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2011-11-09

No results posted yet for this study

Summary

The purpose of this study was to investigate whether the infusion of a medicinal plant (Cissus verticillata L.) would be effective in reducing glucose levels in blood and saliva of type 2 Diabetes patients.

Conditions

Interventions

DRUG

glibenclamide

5 mg as pills, taken daily during the morning for 60 days

OTHER

medicinal plant infusion

INfusion fo Cissus verticillata L., 1 g in 150 mL water, ingested daily for 60 days.

Sponsors & Collaborators

  • Conselho Nacional de Desenvolvimento Científico e Tecnológico

    collaborator OTHER_GOV

  • Federal University of Paraíba

    lead OTHER

Principal Investigators

  • Fabio C Sampaio, PhD · Federal University fo Paraiba

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2009-08-31
Completion
2009-10-31

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01145534 on ClinicalTrials.gov